GLUCOSE AND DIABETIC VASCULAR-DISEASE

被引:345
作者
RUDERMAN, NB
WILLIAMSON, JR
BROWNLEE, M
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MED,DIABET RES CTR,1300 MORRIS PK AVE,F-531, BRONX, NY 10461 USA
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT PATHOL, BRONX, NY 10461 USA
[3] BOSTON UNIV, SCH MED, DEPT MED, BOSTON, MA 02118 USA
[4] BOSTON UNIV, SCH MED, DEPT PHYSIOL, BOSTON, MA 02118 USA
[5] WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA
关键词
PATHOGENESIS; SORBITOL PATHWAY; DIACYLGLYCEROL SYNTHESIS; PROTEIN KINASE-C; MYOINOSITOL TRANSPORT; NA/K-ATPASE; REDOX STATE; GLYCATION; PHARMACOLOGY;
D O I
10.1096/fasebj.6.11.1644256
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The central therapeutic problem in diabetes mellitus is prevention and treatment of the chronic vascular disease associated with this disorder. Prolonged exposure to hyperglycemia is the primary factor associated with the development of diabetes-specific microvascular disease, and the relationship between deranged glucose metabolism and arterial disease is complicated by many other factors that influence atherogenesis in nondiabetics. Until relatively recently, knowledge about diabetic vascular disease was limited mainly to clinical description. New information about abnormal vascular physiology, ultrastructure, biochemistry, cell biology, and molecular biology now makes it possible to understand in an integrated fashion the major specific mechanisms by which hyperglycemia damages diabetic vessels. Continued progress in this area will further optimize the development of safe and effective drugs for the treatment of diabetic vascular disease.
引用
收藏
页码:2905 / 2914
页数:10
相关论文
共 93 条